Evidence map›Paper›PMID 42005562›Full record

ArticleJHLT open2026

Lung transplantation in recipients aged ≥70 years: a single-center experience.

Jan Jelinek, Tomas Kusnirak, Monika Svorcova, Jaromir Vajter, Jan Balko, Gabriela Holubova, Zuzana Ozaniak Strizova, Pavel Pafko, Rene Novysedlak, Jiri Vachtenheim and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in JHLT open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Jan JelinekPrague Lung Transplant Program, 3rd Department of Surgery, First Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic.
Tomas KusnirakFirst Faculty of Medicine, Charles University, Prague, Czechia.
Monika SvorcovaPrague Lung Transplant Program, 3rd Department of Surgery, First Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic.
Jaromir VajterDepartment of Anesthesiology, Resuscitation and Intensive Care Medicine, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic.
Jan BalkoDepartment of Pathology and Molecular Medicine, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic.
Gabriela HolubovaDepartment of Anesthesiology, Resuscitation and Intensive Care Medicine, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic.
Zuzana Ozaniak StrizovaDepartment of Immunology, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic.
Pavel PafkoPrague Lung Transplant Program, 3rd Department of Surgery, First Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic.
Rene NovysedlakPrague Lung Transplant Program, 3rd Department of Surgery, First Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic.
Jiri VachtenheimPrague Lung Transplant Program, 3rd Department of Surgery, First Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic.
Robert LischkePrague Lung Transplant Program, 3rd Department of Surgery, First Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The suitability of lung transplantation (LTx) in recipients aged ≥70 years remains debated, despite reports of acceptable outcomes in selected elderly patients among other solid-organ transplantations. We retrospectively analyzed all LTx procedures performed in this age group within the Prague Lung Transplant Program between January 2012 and July 2025. Twelve patients aged ≥70 years underwent double (n = 5) or single (n = 7) LTx. The median age was 70.3 years. Indications were interstitial pulmonary disease (n = 7) and chronic obstructive pulmonary disease (n = 5). Median waiting time was 199.5 days. Primary graft dysfunction grade 2 occurred in 2 patients, with no cases of grade 3. Median ICU and hospital lengths of stay were 10 and 21.5 days, respectively. One-month and 1-year survival rates were 91.7% and 73%. These data indicate that LTx in carefully selected septuagenarian recipients can achieve favorable short-term outcomes.

Indexed as

Lung transplantationOrgan donationPrimary graft dysfunctionSeptuagenarian lung recipientsTransplant survival

Identifiers

PMID42005562
PMCPMC13091370

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.